Search Results - Torre E

Cost-consequence analysis of sitagliptin versus sulfonylureas as add-on therapy for the treatment of diabetic patients in Italy by Lorenzoni V, Baccetti F, Genovese S, Torre E, Turchetti G

Connect to this object online.

Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study by Torre E, Bruno GM, Di Matteo S, Martinotti C, Valentino MC, Bottaro LC, Colombo GL

Connect to this object online.

Recomendaciones para el tratamiento farmacológico de la hiperglucemia en la diabetes tipo 2 by Menéndez Torre E, Lafita Tejedor J, Artola Menéndez S, Millán Núñez Cortés J, Alonso García A, Puig Domingo M

Connect to this object online.

Economic Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Italy. Analysis and Perspectives by Torre E, Di Matteo S, Martinotti C, Bruno GM, Goglia U, Testino G, Rebora A, Bottaro LC, Colombo GL

Connect to this object online.

Economic Burden of Non-Alcoholic Steatohepatitis (NASH) Among Diabetic Population in Italy: Analysis and Perspectives by Torre E, Di Matteo S, Bruno GM, Martinotti C, Valentino MC, Testino G, Rebora A, Bottaro LC, Colombo GL

Connect to this object online.

Cost-minimization analysis of degludec/liraglutide versus glargine/aspart: economic implications of the DUAL VII study outcomes by Torre E, Bruno GM, Di Matteo S, Martinotti C, Oselin M, Valentino MC, Parodi A, Bottaro LC, Colombo GL

Connect to this object online.

Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus by Torre E, Colombo GL, Di Matteo S, Martinotti C, Valentino MC, Rebora A, Cecoli F, Monti E, Galimberti M, Di Bartolo P, Gaggioli G, Bruno GM

Connect to this object online.